Richard Cloward
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,225 of the $3,669 with a category attached, or 87.9%. It is spread thinly across 34 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$442
- Endo Pharmaceuticals Inc.$440
- 180 Medical, Inc.$353
- Astellas Pharma US Inc$285
- Boston Scientific$280
- Sumitomo Pharma America, Inc.$216
- plus $2K from 28 others
What the payments were for
- Travel & lodging$37410%
- Food & beverage$3,22588%
- Education$692%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 8 | $442 |
| Endo Pharmaceuticals Inc. | 20 | $440 |
| 180 Medical, Inc. | 17 | $353 |
| Astellas Pharma US Inc | 14 | $285 |
| Boston Scientific | 7 | $280 |
| Sumitomo Pharma America, Inc. | 11 | $216 |
| Johnson & Johnson | 9 | $204 |
| Endo USA, Inc. | 11 | $199 |
| Pfizer | 9 | $165 |
| Urovant Sciences Inc | 6 | $131 |
| Travere Therapeutics, Inc. | 6 | $120 |
| Teleflex LLC | 6 | $108 |
| AbbVie | 5 | $85 |
| Convatec Inc. | 4 | $79 |
| Coloplast | 4 | $74 |
| Urogen Pharma, Inc. | 2 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Myriad Genetic Laboratories, Inc. | 3 | $38 |
| ABC Home Medical Supply, Inc. | 2 | $34 |
| Myovant Sciences Inc. | 2 | $31 |
| Verity Pharmaceuticals Inc. | 2 | $30 |
| AstraZeneca | 2 | $30 |
| Polynovo North America LLC | 2 | $29 |
| Laborie Medical Technologies Corp. | 1 | $26 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $21 |
| Medtronic | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Valencia Technologies Corporation | 1 | $14 |
| Conmed Corporation | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$227
- XIAFLEX$122
How this compares
$3,669 in reported general payments places this provider in the 95th percentile of 121 surgical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 16 | $240,456 |
| MyrbetriqMirabegron | 148 | $107,055 |
| Thiola EcTiopronin | 13 | $66,046 |
| Tamsulosin Hcl | 1,131 | $18,823 |
| ElmironPentosan Polysulfate Sodium | 11 | $10,604 |
| OsphenaOspemifene | 17 | $8,334 |
| Finasteride | 555 | $8,054 |
| Estradiol | 90 | $5,421 |
| Potassium Citrate ErPotassium Citrate | 61 | $5,224 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 184 | $3,961 |
| Methenamine Hippurate | 46 | $3,258 |
| Cephalexin | 142 | $2,107 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 121 | $1,728 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,704 |
| Silodosin | 26 | $1,643 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $285 | $347,511164 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 121 surgical providers in Utah.
Other surgical in Ogden
- Karlee KaufmanOgden$1K
- Benjamin WallaceOgden$1K
- James JosephOgden$463
- Mark BennettOgden$449
- Scott HadfieldSalt Lake City$10K
- Brittany CrossSalt Lake City$6K
- Jason HoldenDraper$6K
- Stephen LoperAmerican Fork$5K
- Drew LambourneProvo$4K
- Brittney TaylorSalt Lake City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.